Overview of Allogene Therapeutics Allogene Therapeutics (NASDAQ: ALLO) is a cutting-edge biotechnology company focused on the development of allogeneic (off-the-shelf) CAR-T therapies for cancer treatment. Established in 2018, Allogene is revolutionizing cancer immunotherapy by offering scalable, immediate, and potentially more affordable treatments compared to traditional autologous CAR-T therapies. The company is headquartered in South San […]
Puronix: Bridging Science and Innovation
Unveiling the Core of Biotechnology and Its Real-World Applications